Molecular analysis for diagnosing onychomycosis - PiedRéseau Bromont
PiedRéseau Bromont offers a specialized service for the molecular analysis of onychomycosis, a superficial fungal infection affecting the nails. This advanced diagnostic tool utilizes a skin or nail sample to detect over 50 types of fungi, including dermatophytes, yeasts, and moulds. By employing molecular DNA detection, we provide precise identification of the causative agents, enabling timely and accurate treatment decisions. This service is essential for patients experiencing nail infections, as it allows for the differentiation between onychomycosis and other similar conditions, ensuring the right therapeutic approach is applied.
In the clinical context of PiedRéseau Bromont, the molecular analysis for diagnosing onychomycosis plays a crucial role in the continuum of care offered to our patients. With the high prevalence of superficial fungal infections, accurate diagnosis is vital for effective treatment and prevention of recurrence. Our clinic integrates this molecular analysis within a comprehensive podiatric care framework, utilizing cutting-edge diagnostic technologies to support our patients’ foot health. Results are typically available within seven days, facilitating prompt intervention and management.
The PiedRéseau Bromont team includes Dr. Jean-Philippe B. Chamberland, the founder and podiatrist, who emphasizes diagnostic precision and therapeutic innovation. Dr. Laurence Douville-Dessureault, also a podiatrist, brings a modern approach and expertise in biomechanics. Patricia Courtemanche, an auxiliary nurse in foot care, ensures meticulous patient care during procedures. Émily Leclerc Gagnon and Lysa Gagnon serve as nurse assistants, supporting clinical coordination and patient care. Together, this dedicated team is committed to providing high-quality podiatric services, including the molecular analysis for diagnosing onychomycosis.